A recent study by Zhang et al. (Zhang et al., 2022b) demonstrated that the Nrg4 endocrine axis can arrest the development of HCC by inhibiting the tumor-promoting microenvironment in NASH. Here, NRG4 is linked to metabolic dysfunction-associated steatohepatitis.